Crinetics Pharmaceuticals Inc. (CRNX)

Crinetics Pharmaceuticals Inc.

CRNX

Super Fund	Position	Shares	Curr. Value	Port. %	Activity
Farallon Capital Management	Equity	4,605,098	$154,454,987	0.86%	+13.01%

Total Shares Held: 4,605,098

Total Value Reported: $154,454,987

Average Allocation per Portfolio 0.86%

Largest Single Portfolio Allocation: 0.86%

Largest Shareholder: Farallon Capital Management

Change in Total Shares Held (Q on Q): +407,300

Percentage Change in Shares Held (Q on Q): 9.70%

Number of Current Holders: 1

Number of New Holders (Q on Q): 0

Number of Funds with Additions (Q on Q): 1

Number of Funds with Deductions (Q on Q): 1

Number of Funds Fully Divested (Q on Q): 1

Number of Funds with No Change (Q on Q): 0